Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Marianne Tuefferd"'
Autor:
Xia Wu, Jessica B. Roberto, Allison Knupp, Alexander L. Greninger, Camtu D. Truong, Nicole Hollingshead, Heidi L. Kenerson, Marianne Tuefferd, Antony Chen, David M. Koelle, Helen Horton, Keith R. Jerome, Stephen J. Polyak, Raymond S. Yeung, Ian N. Crispe
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Precision-cut human liver slice cultures (PCLS) have become an important alternative immunological platform in preclinical testing. To further evaluate the capacity of PCLS, we investigated the innate immune response to TLR3 agonist (poly-I:C) and TL
Externí odkaz:
https://doaj.org/article/75336c7dd31743c385e9d9eee84beec0
Autor:
Ellen Van Damme, Kim Thys, Marianne Tuefferd, Carl Van Hove, Jeroen Aerssens, Marnix Van Loock
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164843 (2016)
Human cytomegalovirus (HCMV) is a betaherpesvirus which rarely presents problems in healthy individuals, yet may result in severe morbidity in immunocompromised patients and in immune-naïve neonates. HCMV has a large 235 kb genome with a coding capa
Externí odkaz:
https://doaj.org/article/431d67a5c281450fa1cb80ef1aa91b08
Autor:
Ina Vandenbroucke, Herwig Van Marck, Peter Verhasselt, Kim Thys, Wendy Mostmans, Stéphanie Dumont, Veerle Van Eygen, Katrien Coen, Marianne Tuefferd, Jeroen Aerssens
Publikováno v:
BioTechniques, Vol 51, Iss 3, Pp 67-77 (2011)
Ultra-deep sequencing (UDS) of amplicons is a major application for next-generation sequencing tech nologies, even more so for the 454 Genome Sequencer FLX. Especially for this application, errors that might be introduced during any of the sample pro
Externí odkaz:
https://doaj.org/article/29b23da48c624d15b762778e9046affd
Autor:
Marianne Tuefferd, Jérôme Couturier, Françoise Penault-Llorca, Anne Vincent-Salomon, Philippe Broët, Jean-Paul Guastalla, Djelila Allouache, Martin Combe, Béatrice Weber, Eric Pujade-Lauraine, Sophie Camilleri-Broët
Publikováno v:
PLoS ONE, Vol 2, Iss 11, p e1138 (2007)
Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially impr
Externí odkaz:
https://doaj.org/article/d59996534aba453f8a42346e85b2de2c
Autor:
Lance D. Miller, Patrick Tan, Elaine Lim, Jean-François Régnard, Marianne Tuefferd, Yonghui Wu, Maxime Battistella, Dhinoth Bangarusamy, Marco Alifano, Shenli Zhang, Sophie Camilleri-Broët, Philippe Broët
Supplementary Tables 1-4 from Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba3bd2618bc19f16232df1c1badaae6
https://doi.org/10.1158/0008-5472.22379652
https://doi.org/10.1158/0008-5472.22379652
Autor:
Lance D. Miller, Patrick Tan, Elaine Lim, Jean-François Régnard, Marianne Tuefferd, Yonghui Wu, Maxime Battistella, Dhinoth Bangarusamy, Marco Alifano, Shenli Zhang, Sophie Camilleri-Broët, Philippe Broët
Supplementary Methods from Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d1414a4e2cb35a5231fe571706f32e
https://doi.org/10.1158/0008-5472.22379655.v1
https://doi.org/10.1158/0008-5472.22379655.v1
Autor:
Lance D. Miller, Patrick Tan, Elaine Lim, Jean-François Régnard, Marianne Tuefferd, Yonghui Wu, Maxime Battistella, Dhinoth Bangarusamy, Marco Alifano, Shenli Zhang, Sophie Camilleri-Broët, Philippe Broët
Supplementary Figures 1-6 from Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::964a77122ae61bccbfe37212d3f89f68
https://doi.org/10.1158/0008-5472.22379658.v1
https://doi.org/10.1158/0008-5472.22379658.v1
Autor:
Lance D. Miller, Patrick Tan, Elaine Lim, Jean-François Régnard, Marianne Tuefferd, Yonghui Wu, Maxime Battistella, Dhinoth Bangarusamy, Marco Alifano, Shenli Zhang, Sophie Camilleri-Broët, Philippe Broët
Supplementary Figure Legends 1-6 from Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dcf85421c3eee9232d4bb2c8036966
https://doi.org/10.1158/0008-5472.22379661.v1
https://doi.org/10.1158/0008-5472.22379661.v1
Autor:
Wim Pierson, Marianne Tuefferd, Florence Herschke, Leen Slaets, Marjolein Crabbe, Dorien Verstappen, Steffi De Pelsmaeker, Ian Strickland, Edward J Gane, Christian Schwabe, Yingjie Zhang, Peter Meerts, Joris Vandenbossche, Pieter Van Remoortere, Inge Verbrugge, An De Creus
Publikováno v:
Antiviral Therapy. 28:135965352311728
Background Chronic hepatitis B (CHB) is responsible for major disease burden worldwide. However, the number of available therapies is limited; cure remains an elusive goal. JNJ-64794964 (JNJ-4964) is an oral toll-like receptor-7 (TLR7) agonist being
Autor:
Liviawati S Wu, Yue Hu, Edward J Gane, Leen Slaets, An De Creus, Yanhua Ding, Junqi Niu, Christian Schwabe, Nele Goeyvaerts, Zhongnan Xu, Dandan Huo, Marianne Tuefferd, Inge Verbrugge, Pieter Van Remoortere, Ullrich Schwertschlag, Joris Vandenbossche
Publikováno v:
Antiviral Therapy. 28:135965352311516
Background JNJ-4964 is a TLR7 agonist, which, via a type I interferon (IFN)–dependent mechanism, may enhance host immunity suppressed by persistent exposure to hepatitis B antigens in chronic hepatitis B. Methods PK and PD data were pooled from 2 s